BECTON DICKINSON & CO (BDX)
Data as of , from SEC Form 4 filings.
See up to 3 months of BDX. The 7-day demo opens the 1M and 3M ranges and puts BDX on your watchlist.
Start 7-day demoLatest BDX insider trades
About BECTON DICKINSON & CO (BDX)
BECTON DICKINSON & CO is an SEC registrant, filing under CIK 0000010795, classified as surgical and medical instruments and apparatus. We track it alongside the rest of the Health Care sector.
BDX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 5 | 6,906 | $1.27M |
| Grant or award | 2 | 283 | |
| Option exercise | 2 | 86,556 | |
BDX insider transactions (Form 4)
6196 Form 4 filings on record, the earliest from Nov 5, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Christopher Ian Montague Jones - Director | Grant or award | Rights to Common Stock Under BD Deferred Compensation Plan | 168 | $178.71 | $30K | |
| Open-market sale | Common Stock | 57 | $186.01 | $11K | ||
| Open-market sale | Common Stock | 58 | $181.03 | $10K | ||
| Claire Fraser - Director | Open-market sale | Common Stock | 917 | $187.50 | $172K | |
| Tax withholding / forfeiture | Common Stock | 278 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Stock | 216 | $0.00 | - | ||
| Open-market sale | Common Stock | 57 | $197.99 | $11K | ||
| Tax withholding / forfeiture | Common Stock | 773 | $0.00 | - | ||
| Open-market purchase | Common Stock | 5,250 | $191.57 | $1.01M | ||
| Claire Fraser - Director | Open-market sale | Common Stock | 863 | $192.30 | $166K | |
| Carrie L. Byington - Director | Grant or award | Rights to Common Stock Under BD Deferred Compensation Plan | 34 | $178.25 | $6K | |
| Christopher Ian Montague Jones - Director | Grant or award | Rights to Common Stock Under BD Deferred Compensation Plan | 168 | $178.25 | $30K | |
| Option exercise | Common Stock | 6,360 | $147.68 | $939K | ||
| Derivative | Common Stock | 5,175 | $180.29 | $933K | ||
| Open-market sale | Common Stock | 1,184 | $180.29 | $213K | ||
| Open-market sale | Common Stock | 1 | $181.50 | $182 | ||
| Option exercise | Stock Appreciation Rights | 6,360 | $0.00 | - | ||
| Bilal Muhsin - Officer | Grant or award | Common Stock | 12,221 | $0.00 | - | |
| Open-market sale | Common Stock | 1,166 | $171.19 | $200K | ||
| Christopher Ian Montague Jones - Director | Grant or award | Rights to Common Stock Under BD Deferred Compensation Plan | 145 | $207.09 | $30K | |
| Carrie L. Byington - Director | Grant or award | Rights to Common Stock Under BD Deferred Compensation Plan | 29 | $207.09 | $6K | |
| Open-market sale | Common Stock | 479 | $197.28 | $94K | ||
| Tax withholding / forfeiture | Common Stock | 1,886 | $0.00 | - | ||
| Open-market sale | Common Stock | 2,838 | $223.33 | $634K | ||
| Roland Goette - Officer | Option exercise | Common Stock | 6,995 | $147.68 | $1.03M | |
| Roland Goette - Officer | Option exercise | Common Stock | 6,339 | $167.91 | $1.06M | |
| Roland Goette - Officer | Open-market sale | Common Stock | 4,483 | $221.01 | $991K | |
| Roland Goette - Officer | Derivative | Common Stock | 9,490 | $221.01 | $2.10M | |
| Roland Goette - Officer | Open-market sale | Common Stock | 638 | $219.03 | $140K | |
| Roland Goette - Officer | Option exercise | Stock Appreciation Rights | 6,995 | $0.00 | - | |
| Roland Goette - Officer | Option exercise | Stock Appreciation Rights | 6,339 | $0.00 | - | |
| Open-market sale | Common Stock | 1,000 | $220.49 | $220K | ||
| Open-market sale | Common Stock | 1,500 | $220.25 | $330K | ||
| Pavan Kumar Mocherla - Officer | Grant or award | Common Stock | 875 | $0.00 | - | |
| Pavan Kumar Mocherla - Officer | Grant or award | Common Stock | 180 | $0.00 | - | |
| Pavan Kumar Mocherla - Officer | Tax withholding / forfeiture | Common Stock | 20 | $0.00 | - | |
| Pavan Kumar Mocherla - Officer | Grant or award | Stock Appreciation Rights | 3,426 | $0.00 | - | |
| Grant or award | Common Stock | 2,109 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Stock | 509 | $0.00 | - | ||
| Grant or award | Stock Appreciation Rights | 8,264 | $0.00 | - | ||
| Grant or award | Common Stock | 1,932 | $0.00 | - | ||
| Grant or award | Common Stock | 416 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Stock | 376 | $0.00 | - | ||
| Grant or award | Stock Appreciation Rights | 7,568 | $0.00 | - | ||
| Grant or award | Rights to Common Stock Under Deferred Compensation Plan | 416 | $0.00 | - | ||
| Thomas E. Polen Jr. - Officer | Grant or award | Common Stock | 15,539 | $0.00 | - | |
| Thomas E. Polen Jr. - Officer | Grant or award | Common Stock | 36,585 | $0.00 | - | |
| Thomas E. Polen Jr. - Officer | Tax withholding / forfeiture | Common Stock | 23,564 | $0.00 | - | |
| Thomas E. Polen Jr. - Officer | Grant or award | Stock Appreciation Rights | 60,891 | $0.00 | - | |
| Grant or award | Common Stock | 2,220 | $0.00 | - | ||
| Grant or award | Common Stock | 2,275 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Stock | 1,204 | $0.00 | - | ||
| Grant or award | Stock Appreciation Rights | 8,699 | $0.00 | - | ||
| Grant or award | Common Stock | 4,884 | $0.00 | - | ||
| Grant or award | Common Stock | 9,015 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Stock | 5,192 | $0.00 | - | ||
| Grant or award | Stock Appreciation Rights | 19,138 | $0.00 | - | ||
| Antoine C. Ezell - Officer | Grant or award | Common Stock | 1,388 | $0.00 | - | |
| Antoine C. Ezell - Officer | Grant or award | Common Stock | 2,619 | $0.00 | - | |
| Antoine C. Ezell - Officer | Tax withholding / forfeiture | Common Stock | 1,357 | $0.00 | - | |
| Antoine C. Ezell - Officer | Grant or award | Stock Appreciation Rights | 5,437 | $0.00 | - |
See every BDX filing on record
These pages show the latest 90 of 96 Form 4 filings on record. The 7-day demo shows all 96, and sign-up brings you back to this table.
Recent BDX Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| MICHAEL FELD | Officer | 76 | $14K | View on EDGAR | |
| MICHAEL FELD | Officer | 165 |
Stock trades in BDX disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
| Sale |
BDX insider trading FAQ
What is the latest insider trade for BDX?
BECTON DICKINSON & CO (BDX) had 9 insider filings in the last 90 days, with the most recent on 2026-09-30. The full record for BDX runs to 96 Form 4 filings, the earliest from 2024-11-05. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BDX stock?
No insider purchases of BDX were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling BDX stock?
5 insider sales of BDX were filed in the last 90 days, totaling $1.27M.
Where can I see BDX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BDX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Michael Feld view on EDGAR
- - Vitor Roque view on EDGAR
- - Michael Feld view on EDGAR
- - Michael Feld view on EDGAR
- - Thomas E. Polen Jr. view on EDGAR
- - Roland Goette view on EDGAR
- - Robert Luther Huffines view on EDGAR
- - Carrie L. Byington view on EDGAR
- - Michael Feld view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where BDX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BDX with a 7-day demo
- BDX on your watchlist
- Every BDX Form 4 filing on record
- Up to 3 months of BDX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive